Next-Generation Therapies for Hedgehog Pathway-Dependent Tumors |
Lucile Packard Children's Hospital at Stanford University School of Medicine / James Chen, PhD |
Innovation Grants |
2013 |
California |
Epigenetic Characterization of the Neuroblastoma Driver Genes ARID1A and ARID1B |
Children's Hospital of Philadelphia / Michael Hogarty, MD |
Innovation Grants |
2013 |
Pennsylvania |
Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers |
Dana-Farber Cancer Institute / Charles Roberts, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma |
Columbia University Medical Center / Darrell Yamashiro, MD, PhD |
Innovation Grants |
2013 |
New York |
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma |
Duke University / Corinne Mary Linardic, MD, PhD |
Innovation Grants |
2013 |
North Carolina |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Novel Targeted Therapies for Rhabdomyosarcoma |
St. Jude Children's Research Hospital / Michael Dyer, PhD |
Innovation Grants |
2013 |
Tennessee |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG) |
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Innovation Grants |
2013 |
Texas |